Close

Covidien (COV) Tops Q1 EPS by 2c

April 27, 2012 6:25 AM EDT
Covidien (NYSE: COV) reported Q1 EPS of $1.05, $0.02 better than the analyst estimate of $1.03. Revenue for the quarter came in at $2.95 billion versus the consensus estimate of $2.9 billion.

For earnings history and earnings-related data on Covidien (COV) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings